Lung transplantation represents a viable therapeutic option to consider for patients with end-stage lung disease due to systemic sclerosis (SSc) who have limited extrapulmonary manifestations. PubMed, Curr Opin Rheumatol. 2013 Nov;25(6):714-8. (Also see: Pulmonary Fibrosis Treatments: Lung Transplants)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.